Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 37, Pages 13475-13480
Publisher
Proceedings of the National Academy of Sciences
Online
2014-08-06
DOI
10.1073/pnas.1406663111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation
- (2014) Timothy J. Henrich et al. ANNALS OF INTERNAL MEDICINE
- Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification
- (2014) E. Fabian Cardozo et al. JOURNAL OF THEORETICAL BIOLOGY
- HIV-1 persistence in CD4+ T cells with stem cell–like properties
- (2014) Maria J Buzon et al. NATURE MEDICINE
- New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
- (2014) C Korin Bullen et al. NATURE MEDICINE
- Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
- (2014) Courtney V. Fletcher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy
- (2014) A. R. Cillo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Loss and Recovery of Genetic Diversity in Adapting Populations of HIV
- (2014) Pleuni S. Pennings et al. PLoS Genetics
- Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
- (2013) Ya-Chi Ho et al. CELL
- An Integrated Overview of HIV-1 Latency
- (2013) Debbie S. Ruelas et al. CELL
- BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
- (2013) Daniela Boehm et al. CELL CYCLE
- A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
- (2013) A. M. Spivak et al. CLINICAL INFECTIOUS DISEASES
- Modelling HIV-1 2-LTR dynamics following raltegravir intensification
- (2013) R. Luo et al. Journal of the Royal Society Interface
- Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
- (2013) Deborah Persaud et al. NEW ENGLAND JOURNAL OF MEDICINE
- Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy
- (2013) Wolfgang Stöhr et al. PLoS One
- Reactivation of latent HIV by histone deacetylase inhibitors
- (2013) Kotaro Shirakawa et al. TRENDS IN MICROBIOLOGY
- Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient
- (2013) Steven A. Yukl et al. PLoS Pathogens
- Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
- (2013) Asier Sáez-Cirión et al. PLoS Pathogens
- Control of HIV Latency by Epigenetic and Non-Epigenetic Mechanisms
- (2012) Jonathan Karn et al. CURRENT HIV RESEARCH
- Bromodomain and Extra-terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein
- (2012) Koen Bartholomeeusen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro
- (2012) Brian A. DeChristopher et al. Nature Chemistry
- Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
- (2012) Daniel I S Rosenbloom et al. NATURE MEDICINE
- A quantitative basis for antiretroviral therapy for HIV-1 infection
- (2012) Benjamin L Jilek et al. NATURE MEDICINE
- HIV Model Parameter Estimates from Interruption Trial Data including Drug Efficacy and Reservoir Dynamics
- (2012) Rutao Luo et al. PLoS One
- Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection
- (2012) N. M. Archin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Developing strategies for HIV-1 eradication
- (2012) Christine M. Durand et al. TRENDS IN IMMUNOLOGY
- Reactivation of Latent HIV-1 by Inhibition of BRD4
- (2012) Jian Zhu et al. Cell Reports
- Standing Genetic Variation and the Evolution of Drug Resistance in HIV
- (2012) Pleuni Simone Pennings PLoS Computational Biology
- Curing HIV: Pharmacologic Approaches to Target HIV-1 Latency
- (2011) Shailesh K. Choudhary et al. Annual Review of Pharmacology and Toxicology
- Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation
- (2011) S. Xing et al. JOURNAL OF VIROLOGY
- Early infection and spread of a conditionally replicating adenovirus under conditions of plaque formation
- (2011) Andrew Hofacre et al. VIROLOGY
- Stochastic Theory of Early Viral Infection: Continuous versus Burst Production of Virions
- (2011) John E. Pearson et al. PLoS Computational Biology
- A Stochastic Model of Latently Infected Cell Reactivation and Viral Blip Generation in Treated HIV Patients
- (2011) Jessica M. Conway et al. PLoS Computational Biology
- Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
- (2010) Tae-Wook Chun et al. AIDS
- Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection
- (2010) Nancie M. Archin et al. PLoS One
- Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
- (2010) Rajeev Mehla et al. PLoS One
- Epigenetic regulation of HIV latency
- (2010) Shweta Hakre et al. Current Opinion in HIV and AIDS
- The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
- (2010) Rajesh T. Gandhi et al. PLOS MEDICINE
- Stochastic gene expression as a molecular switch for viral latency
- (2009) Abhyudai Singh et al. CURRENT OPINION IN MICROBIOLOGY
- Establishment and maintenance of HIV latency: model systems and opportunities for intervention
- (2009) Matthew D Marsden et al. Future Virology
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
- (2009) J. B. Dinoso et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
- (2008) Lin Shen et al. NATURE MEDICINE
- HIV rebounds from latently infected cells, rather than from continuing low-level replication
- (2008) B. Joos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now